• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《MiR-363通过调节蜗牛诱导的上皮-间质转化抑制上皮性卵巢癌顺铂耐药性》勘误

Erratum to: MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.

作者信息

Cao Lanqin, Wan Qian, Li Fengjie, Tang Can-E

机构信息

Department of Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P. R., China.

The Institute of Medical Science Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P. R., China.

出版信息

BMB Rep. 2019 Mar;52(3):226.

PMID:30909989
Abstract

The BMB Reports would like to correct in the Supplementary Figure 1 of BMB Rep. 51(9): 456-461 titled "MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition."

摘要

《BMB报告》希望对发表于《BMB报告》第51卷第9期第456 - 461页、标题为“MiR - 363通过调节蜗牛诱导的上皮-间质转化抑制上皮性卵巢癌的顺铂化疗耐药性”的文章中的补充图1进行更正。

相似文献

1
Erratum to: MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.《MiR-363通过调节蜗牛诱导的上皮-间质转化抑制上皮性卵巢癌顺铂耐药性》勘误
BMB Rep. 2019 Mar;52(3):226.
2
MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.miR-363 通过调控 snail 诱导的上皮-间质转化抑制上皮性卵巢癌对顺铂的化疗耐药性。
BMB Rep. 2018 Sep;51(9):456-461. doi: 10.5483/BMBRep.2018.51.9.104.
3
Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.《环状RNA circSnx12通过miR-194-5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性》的勘误
BMB Rep. 2024 Feb;57(2):122.
4
Erratum to: circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.《环状RNA circSnx12通过miR-194-5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性》的勘误
BMB Rep. 2023 Jul;56(7):416.
5
FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.FOXM1赋予上皮性卵巢癌细胞上皮-间质转化、干性和化疗耐药性。
Oncotarget. 2015 Feb 10;6(4):2349-65. doi: 10.18632/oncotarget.2957.
6
Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer.miR-136的表达与人上皮性卵巢癌的原发性顺铂耐药相关。
Oncol Rep. 2015 Feb;33(2):591-8. doi: 10.3892/or.2014.3640. Epub 2014 Dec 2.
7
NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.NANOG调节卵巢癌中的上皮-间质转化和化疗耐药性。
Biosci Rep. 2017 Jan 10;37(1). doi: 10.1042/BSR20160247. Print 2017 Feb 28.
8
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.顺铂治疗原发性和转移性上皮性卵巢癌会产生间充质干细胞样表型的残留细胞。
J Cell Biochem. 2011 Oct;112(10):2850-64. doi: 10.1002/jcb.23199.
9
DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.DYRK2通过降解卵巢浆液性腺癌中的Snail来调控上皮-间质转化和化学敏感性。
Tumour Biol. 2015 Aug;36(8):5913-23. doi: 10.1007/s13277-015-3264-y. Epub 2015 Feb 25.
10
Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.通过 AKT/β-连环蛋白/Snail 信号通路在顺铂耐药肺癌细胞中获得上皮-间充质转化表型和癌症干细胞样特性。
Eur J Pharmacol. 2014 Jan 15;723:156-66. doi: 10.1016/j.ejphar.2013.12.004. Epub 2013 Dec 12.